A buyer’s briefing · July 29, 2026
Turnkey weight-loss, peptide, and metabolic-clinic offers ask for six figures on the seller’s terms. This briefing hands you the buyer’s terms: the questions, the math, and the documents that decide whether you build an asset or rent one.
If you are reading this, you are probably weighing an offer to “own your own” weight-loss, peptide, hormone, or metabolic-wellness clinic — a turnkey business someone will build for you for somewhere between roughly one hundred thousand and half a million dollars. The offers are polished. The market is real. And most are structured so the evaluation happens on the seller’s terms, using the seller’s numbers, on a call the seller sets up. This briefing is the other side of that table.
The number that gets your attention is the price of admission. The number that decides whether you own an asset or rent one is what you pay every year after that — the royalty on your gross revenue, the brand-fund percentage, the mandated marketing spend, the monthly minimums that apply whether or not you are profitable yet. In the franchise offers we have examined, published ongoing takes range from around 6% of gross to 10% of gross plus minimums plus required marketing spend — figures dated from each company’s 2025 disclosure materials, and each company’s current Franchise Disclosure Document controls. A percentage of gross compounds against you precisely when you succeed. Before you compare entry fees, total the ten-year ongoing take at your own projected revenue. We built a free calculator that does exactly that.
Franchises give you a known brand, real training, and a disclosure document you can actually read — in exchange for an ongoing royalty and a brand you never own. Read Item 6 (the fees) and Item 19 (the earnings representation, if there is one) before anything else. Direct sellers and “licensors” often advertise no royalty and full ownership — an attractive structure when the terms are real. The questions to ask: how old is the company, what exactly is a six-figure “deposit” rebated against, and is there any written disclosure document behind an earnings-type claim? Treat a missing document as a diligence flag. Each family rewards a different set of questions. We publish both.
Whatever the offer, three questions cut through it. One: what does the full ongoing cost total over ten years at my realistic revenue — not the entry fee, the whole take? Two: what does the actual document say — the FDD, or if there is no FDD, the written terms — as opposed to what the salesperson says? Three: what do I own at the end — the brand, the customer list, the location goodwill — if I decide to leave? If an offer gets worse the more precisely you ask these, that is the answer.
We are Atlas Metabolic. We sell a competing model in this same category: a 0%-royalty license under which the operator owns their own brand, with final terms controlled by a written agreement. So read everything here as coming from an interested party — and then hold us to the exact same three questions. That is the point. We think the honest comparison — documents, ten-year cost, ownership at exit — favors the structure we chose, and the fastest way to see whether that claim survives is to run the diligence on everyone, us included. We would rather earn a buyer who did that than one who didn’t.
These three resources are published by Atlas Metabolic and are free, ungated, and built to be used against every offer in this category: